论著

抗菌药物管理协作干预改进抗菌药物使用前微生物标本送检

展开
  • a. 浦东新区人民医院医院 感染管理科,上海 201299
    b. 浦东新区人民医院医院 检验科,上海 201299
    c. 浦东新区人民医院医院 检验科,上海 201299

收稿日期: 2018-10-12

  网络出版日期: 2019-02-25

基金资助

上海市浦东新区卫生系统学科带头培养计划(PWRd2014-18);上海市浦东新区卫生系统重点学科建设资助(PWZxk2017-24);上海市浦东新区科技发展基金(PKJ2018-Y13)

Antimicrobial stewardship enhancing the submission rate of microbiological specimens before therapeutic use of antimicrobial agents

Expand
  • a. Section of Infection Management, Shanghai 201299, China
    b. Section of Infection Management, Department of Clinical Laboratory, Shanghai 201299, China
    c. Department of Respiratory, New Pudong District People′s Hospital, Shanghai 201299, China

Received date: 2018-10-12

  Online published: 2019-02-25

摘要

目的 探讨抗菌药物管理(antimicrobial stewardship, AMS)协作干预对治疗性使用抗菌药物前微生物标本送检的改进效果。方法 2017年1月至2017年6月为抗菌药物管理干预前,2017年7月至2017年12月为干预后,比较干预前后全院各临床科室住院患者治疗性使用抗菌药物前微生物标本总送检率、接受限制使用级以及特殊使用级抗菌药物前微生物标本送检率,并比较干预前后送检标本的构成比。结果 微生物标本总送检率、接受限制使用级抗菌药物前微生物标本送检率和接受特殊使用级抗菌药物前微生物标本分别由AMS干预前的49.46%、47.82%和69.91%提高至干预后的61.94%、62.11%和83.45%,差异有统计学意义(P均<0.01)。本院各重点科室干预后接受限制使用级抗菌药物前微生物标本送检率除了普外科和妇产科外,接受特殊使用级抗菌药物前微生物标本送检率除了妇产科外,均达到了考核标准。干预后送检标本中的呼吸道标本占比由53.46%降至51.66%(P<0.01),血培养标本由11.96%升至15.32%(P<0.01),无菌体液标本由3.60%升至4.10%(P<0.05)。结论 通过AMS协作干预有效提高了治疗性使用抗菌药物前的微生物标本送检率,改进送检标本质量,为抗菌药物的合理使用提供了实验室依据。

本文引用格式

吴浩, 房华, 汪瑞忠, 瞿静华, 沈孝峰, 陈华萍, 顾文超 . 抗菌药物管理协作干预改进抗菌药物使用前微生物标本送检[J]. 诊断学理论与实践, 2019 , 18(1) : 93 -97 . DOI: 10.16150/j.1671-2870.2019.01.019

Abstract

Objective: To investigate the effect of antimicrobial stewardship(AMS) on enhancing submission rate of microbiological specimens before therapeutic use of antimicrobial agents. Methods:January 2017 to June 2017 was the pre-intervention group; July 2017 to September 2017 was the post-intervention group. Submission rate of microbiological specimens before therapeutic use of antimicrobial agents were compared between the two groups. Constituent ratio of different microbiological specimens was also compared between the two groups. Results: The submission rates of microbiolo-gical specimens for general, restricted and special therapeutic use of antimicrobial agents before and after AMS increased from 49.46%, 47.82%, 69.91% to 61.94%, 62.11%, 83.45%, respectively (P all <0.01). The submission rate of microbiological specimens for general and special therapeutic use of antimicrobial agents before and after AMS in key departments reached the assessment criteria.The constituent ratio of sputum culture specimen was decreased from 53.46% to 51.66%( P<0.01), and the constituent ratio of blood culture and aseptic humoral specimen increased from 11.96% and 3.60% to 15.32% and 4.10%(P<0.01, P<0.05). Conclusions: AMS can effectively improve the submission rate of microbiological specimens before therapeutic use of antimicrobial agents and the quality of specimens for inspection; it provides laboratory evidence for the rational use of antibiotics.

参考文献

[1] Reed EE, Stevenson KB, West JE, et al. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program[J]. Virulence, 2013, 4(2):158-162.
[2] Chahine EB, El-Lababidi RM, Sourial M. Engaging Pharmacy Students, Residents, and Fellows in Antimicrobial Stewardship[J]. J Pharm Pract, 2015, 28(6):585-591.
[3] Shlaes DM. Role of Antimicrobial Stewardship in Prevention and Control of Antibiotic Resistance[J]. Curr Infect Dis Rep, 1999, 1(4):334-337.
[4] 杨婧, 杨蕾, 刘姗, 等. 选择式目标管理提高临床微生物标本送检率[J]. 中国感染控制杂志, 2015, 14(5):342-343.
[5] 《抗菌药物临床应用指导原则2015版 》(国卫办医发〔2015〕43号)[EB/OL]. http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml.
[6] 《关于进一步开展全国抗菌药物临床应用专项整治活动的通知》(卫办医政发〔2013〕37号)[EB/OL]. http://www.nhc.gov.cn/yzygj/s3585u/201305/823b9d131ff4416ab7b41b2c4e1f0e83.shtml.
[7] Dixon J, Duncan CJ. Importance of antimicrobial stewardship to the English National Health Service[J]. Infect Drug Resist, 2014, 7:145-152.
[8] Lew KY, Ng TM, Tan M, et al. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting[J]. J Antimicrob Chemother, 2015, 70(4):1219-1225.
[9] 韩冰, 隋忠国, 李祥鹏, 等. 48家医疗机构抗菌药物管理体系建设情况分析[J]. 中国执业药师, 2016, 13(9):40-44.
[10] 赵泉, 王颖琳, 张雷, 等. 某三级甲等医院抗菌药物科学化管理实践与思考[J]. 中国药业, 2017, 26(18):92-94.
[11] 宋珍, 黄卫春, 顾飞飞, 等. 住院肺炎患儿呼吸道标本分离菌及其耐药性分析[J]. 诊断学理论与实践, 2016, 15(4):421-425.
[12] 刘波, 张卫红, 李松琴, 等. 提高微生物标本送检率的临床效果评价[J]. 中国感染控制杂志, 2016, 15(11):862-864.
[13] 殷俊, 常啸, 程君, 等. 安徽省某三甲医院铜绿假单胞菌分布及耐药特点研究[J]. 安徽医学, 2018, 39(9):1088-1090.
[14] 胡付品, 郭燕, 朱德妹, 等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2017, 17(5):481-491.
[15] 林佳冰, 高晓东, 崔扬文, 等. 上海市90所医院临床病原学标本送检及耐药菌检出现状分析[J]. 中华医院感染学杂志, 2018, 28(8):1162-1165.
文章导航

/